Cell No. : Cell Name
RCB0142 : Ehrlich
update : 2024/12/06
|
| Comment | Ehrlich's ascite tumor |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Kurita, Kaoru
|
| Year of deposit |
1987
|
| Animal |
_mouse
< Mammals
|
| Tissue |
ascites
|
| Disease name |
ascite tumor
|
| Classification |
cancer
|
| History |
Maintained in vivo.
|
|
Lifespan |
infinite
|
| Morphology |
lymphocyte-like
|
| Cellosaurus(Expasy) |
CVCL_3873
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture method |
|
General Guidelines for Culturing Suspension Cells, 浮遊細胞の培養に関する一般的な注意(Japanese)
|
| Culture medium |
|
DMEM (low glucose) + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage ratio |
|
1 : 10 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| SSLP(mouse) |
|
OK
|
| Isozyme |
|
LD, NP
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
3
|
| User's Publication |
11
|
| User's Publication |
|
22430
Kono Y, Fushimi A, Yoshizawa Y, Higaki K, Ogawara KI.
Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites
Int J Pharm
2022
623:121904
PubMed ID: 35716981
DOI: 10.1016/j.ijpharm.2022.121904
|
|
19499
Nguyen TD, Miyatake Y, Yoshida T, Kawahara H, Hanayama R.
Tumor-secreted proliferin-1 regulates adipogenesis and lipolysis in cachexia
Int J Cancer
2021
148(8):1982-1992
PubMed ID: 33252827
DOI: 10.1002/ijc.33418
|
|
13405
Kato S, Saitoh Y, Miwa N.
Carcinostatic effects of alkanoyl ascorbate plus platinum nano-colloid and stabilization of the esterolytically resultant ascorbate by hydrogen.
Hum Cell
2021
PubMed ID: 33387361
DOI: 10.1007/s13577-020-00462-3
|
|
13284
Kamimura M, Sasaki A, Watanabe S, Tanaka S, Fukukawa A, Takeda K, Nakamura Y, Nakamura T, Kuramochi K, Otani Y, Hashimoto F, Ishimaru K, Matsuo T, Okamoto S.
Chemical and molecular bases of dome formation in human colorectal cancer cells mediated by sulphur compounds from Cucumis melo var. conomon.
FEBS Open Bio
2020
PubMed ID: 33048473
DOI: 10.1002/2211-5463.13001
|
|
12862
Saitoh Y, Ikeshima M, Kawasaki N, Masumoto A, Miwa N.
Transient generation of hydrogen peroxide is responsible for carcinostatic effects of hydrogen combined with platinum nanocolloid, together with increases intracellular ROS, DNA cleavages, and proportion of G2/M-phase
Free Radic Res
2016
50(4):385-95
PubMed ID: 26652652
DOI: 10.3109/10715762.2015.1131823
|
|
7298
Saitoh Y, Yoshimoto T, Kato S, Miwa N.
Synergic carcinostatic effects of ascorbic acid and hyperthermia on Ehrlich ascites tumor cell.
Exp. Oncol.
2015
37:94-9
PubMed ID: 26112934
|
|
9472
Yasuyuki Kitaura, Kana Inoue, Naoki Kato, Nahomi Matsushita, Yoshiharu Shimomura
Enhanced Oleate Uptake and Lipotoxicity Associated With Laurate
FEBS Open Bio . 2015 May 29;5:485-91
2015
5:485-91
PubMed ID: 26106523
DOI: 10.1016/j.fob.2015.05.008
|
|
15831
Kono Y, Kawakami S, Higuchi Y, Maruyama K, Yamashita F, Hashida M.
Antitumor effect of nuclear factor-κB decoy transfer by mannose-modified bubble lipoplex into macrophages in mouse malignant ascites
Cancer Sci
2014
105(8):1049-55
PubMed ID: 24850474
DOI: 10.1111/cas.12452
|
|
16151
Hirai M, Minematsu H, Hiramatsu Y, Kitagawa H, Otani T, Iwashita S, Kudoh T, Chen L, Li Y, Okada M, Salomon DS, Igarashi K, Chikuma M, Seno M.
Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells
Int J Pharm
2010
391(1-2):274-83
PubMed ID: 20211714
DOI: 10.1016/j.ijpharm.2010.02.030
|
|
18821
Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Masaki T, Fukui H.
Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model
Int J Cancer
2003
105(3):340-6
PubMed ID: 12704667
DOI: 10.1002/ijc.11094
|
|
1399
Eki T, Enomoto T, Masutani C, Miyajima A, Takada R, Murakami Y, Ohno T, Hanaoka F, Ui M
Mouse DNA primase plays the principal role in determination of permissiveness for polyomavirus DNA replication.
J Virol
1991
65:4874-81
PubMed ID: 1651410
DOI: 10.1128/JVI.65.9.4874-4881.1991
|
Back
Top
CELL BANK Website